Visterra Inc.
Ketan Deotale possesses extensive experience in program and alliance management, with a focus on therapeutic candidates for kidney diseases, currently serving as Senior Manager at Visterra Inc. since October 2014. Ketan's career trajectory includes roles ranging from Associate Scientist to Senior Research Associate, contributing to antibody engineering and assay development. Previous positions at Genzyme involved developing assays for recombinant proteins, while roles at Olympus Biotech and Cerulean Pharma entailed biochemical characterization and method development, respectively. Ketan began a career in research at DePuy Mitek, exploring anti-inflammatory compounds, and has a strong academic background with an MBA from Isenberg School of Management and degrees in Biotechnology and Biology.
Visterra Inc.
1 followers
Visterra, Inc. engages in pharmaceutical drug research and development of therapeutic and diagnostic products for infectious diseases. It also provides structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry. The company was formerly known as Parasol Therapeutics, Inc. andchanged its name in May 2010. Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.